Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Behandling af peritoneale metastaser fra kolorektal cancer

Nielsen, Jesper Clausen and Verwaal, Victor Jilbert LU (2022) In Ugeskrift for Laeger 184(31). p.1-7
Abstract

Ten per cent of patients with colorectal cancer will develop peritoneal metastases. These metastases are known to have a lesser response to systemic chemotherapy than liver- and lung metastases. Randomized studies have shown that adding cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) to this treatment gives a better chance of survival. Recently, a randomized study failed to show a difference in survival between cytoreductive surgery plus HIPEC versus cytoreductive surgery alone. These facts are summarized in this review.

Please use this url to cite or link to this publication:
author
and
alternative title
Treatment of peritoneal metastases from colorectal cancer
publishing date
type
Contribution to specialist publication or newspaper
publication status
published
keywords
Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Colorectal Neoplasms/pathology, Combined Modality Therapy, Cytoreduction Surgical Procedures, Humans, Hyperthermia, Induced, Peritoneal Neoplasms/drug therapy
in
Ugeskrift for Laeger
volume
184
issue
31
pages
1 - 7
publisher
Den Almindelige Danske Lægeforening
external identifiers
  • pmid:35959828
ISSN
0041-5782
language
Danish
LU publication?
no
id
01c9b2e9-46ec-4b9d-b7cd-fb34e58a7bfb
alternative location
https://ugeskriftet.dk/files/scientific_article_files/2022-08/v09210707_web.pdf
date added to LUP
2022-08-18 18:38:17
date last changed
2022-08-19 07:12:47
@misc{01c9b2e9-46ec-4b9d-b7cd-fb34e58a7bfb,
  abstract     = {{<p>Ten per cent of patients with colorectal cancer will develop peritoneal metastases. These metastases are known to have a lesser response to systemic chemotherapy than liver- and lung metastases. Randomized studies have shown that adding cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) to this treatment gives a better chance of survival. Recently, a randomized study failed to show a difference in survival between cytoreductive surgery plus HIPEC versus cytoreductive surgery alone. These facts are summarized in this review.</p>}},
  author       = {{Nielsen, Jesper Clausen and Verwaal, Victor Jilbert}},
  issn         = {{0041-5782}},
  keywords     = {{Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/pathology; Combined Modality Therapy; Cytoreduction Surgical Procedures; Humans; Hyperthermia, Induced; Peritoneal Neoplasms/drug therapy}},
  language     = {{dan}},
  month        = {{08}},
  number       = {{31}},
  pages        = {{1--7}},
  publisher    = {{Den Almindelige Danske Lægeforening}},
  series       = {{Ugeskrift for Laeger}},
  title        = {{Behandling af peritoneale metastaser fra kolorektal cancer}},
  url          = {{https://ugeskriftet.dk/files/scientific_article_files/2022-08/v09210707_web.pdf}},
  volume       = {{184}},
  year         = {{2022}},
}